Digital 4th NASH USA Summit
December 15 - 18, 2020 - MA USHanson Wade
info@hansonwade.com
Phone:+16174554188
The Digital NASH Summit offers an unrivaled, market-leading opportunity to learn cutting-edge insights into the successes, setbacks, and innovations in NASH drug development from the last 12 months. As the only totally comprehensive forum covering all aspects of NASH drug development from mechanistic science through to market access intelligence, this exclusively NASH dedicated conference is the meeting of the year in the NASH biopharma calendar. Join over 75 speakers and 300 attendees across 4 days of unrivaled depth and breadth of discussion broken down into: - 4 tracks hosting scientific case studies and thought-leading panel analysis of discovery, translational and clinical drug development, and non-invasive biomarker application in the clinical algorithm of care - 6 discussion-driven, expert-led workshops into epigenetics, targeting the inflammasome, assessing translational models and non-invasive evaluations of NAFLD and NASH; understanding NASH associated-hepatocellular carcinoma, drug safety in NASH, and regulatory and clinical considerations for pediatric NASH - 1 forward-thinking seminar dedicated to applying relationships and lessons learned from wider anti-fibrotic drug development for pulmonary, renal and cardiac fibrosis to hepatic fibrosis Join 300+ attendees as the community comes together again to address challenges and the consequences of change in the next generation of the NASH market.